CONCORD
Start SIP
Invest Now
Start SIP in CONCORD
Performance
- Low
- ₹0
- High
- ₹0
- 52 Week Low
- ₹0
- 52 Week High
- ₹0
- Open Price₹0
- Previous Close₹0
- Volume
- 50 DMA₹80.10
- 100 DMA₹73.18
- 200 DMA₹62.68
Investment Returns
- Over 1 Month -2.53%
- Over 3 Month + 24.65%
- Over 6 Month + 29.09%
- Over 1 Year + 125.06%
Smart Investing Starts Here Start SIP with Concord Drugs for Steady Growth!
Concord Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
Concord Drugs Financials
Concord Drugs Technicals
EMA & SMA
Current Price
₹81.50
+
0.3
(0.37%)
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹83.49
- 50 Day
- ₹80.10
- 100 Day
- ₹73.18
- 200 Day
- ₹62.68
Resistance and Support
81.7
- R3 87.28
- R2 85.59
- R1 83.39
- S1 79.50
- S2 77.81
- S3 75.61
Concord Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-07-03 | Preferential issue of shares | |
| 2025-06-27 | Preferential Issue of shares & Others | Inter-alia, to consider 1. the date, time, and venue for convening an ExtraOrdinary General Meeting of the Company. 2. Other business matters. |
| 2025-05-23 | Audited Results |
Concord Drugs F&O
About Concord Drugs
- NSE Symbol
- CONCORD
- BSE Symbol
- 538965
- Chairman & Managing Director
- Mr. Sudhir Vaid
- ISIN
- INE858L01010
Similar Stocks to Concord Drugs
Concord Drugs FAQs
Concord Drugs share price is ₹81 As on 14 January, 2026 | 09:32
The Market Cap of Concord Drugs is ₹107.4 Cr As on 14 January, 2026 | 09:32
The P/E ratio of Concord Drugs is 186.6 As on 14 January, 2026 | 09:32
The PB ratio of Concord Drugs is 2.9 As on 14 January, 2026 | 09:32
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.